![glutathione pulmonary fibrosis Idiopathic Fibrosis: Regulation, Cytokine Signaling, and Gaps in Our Knowledge[v1] Pulmonary Fibrosis Secondary to Oxaliplatin](https://www.preprints.org/frontend/picture/ms_xml/manuscript/faa5b60855a057fe9f82b1c4ab60a25d/preprints-112394-g001.png)
glutathione pulmonary fibrosis Idiopathic Fibrosis: Regulation, Cytokine Signaling, and Gaps in Our Knowledge[v1] Pulmonary Fibrosis Secondary to Oxaliplatin
Description
PARP11 has recently been identified as an anti-ZIKV ISG that interacts with PARP12 to enhance ZIKV NS1 and NS3 protein degradation 65
![glutathione pulmonary fibrosis Idiopathic Fibrosis: Regulation, Cytokine Signaling, and Gaps in Our Knowledge[v1] Pulmonary Fibrosis Secondary to Oxaliplatin](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40487-020-00127-z/MediaObjects/40487_2020_127_Fig1_HTML.jpg)
IUBMB Life (2009) 61(5):5105
![glutathione pulmonary fibrosis Idiopathic Fibrosis: Regulation, Cytokine Signaling, and Gaps in Our Knowledge[v1] Pulmonary Fibrosis Secondary to Oxaliplatin](https://pubs.rsc.org/en/Content/Image/GA/C9CC03814K)
Whats the difference between Medicare and Medicaid
![glutathione pulmonary fibrosis Idiopathic Fibrosis: Regulation, Cytokine Signaling, and Gaps in Our Knowledge[v1] Pulmonary Fibrosis Secondary to Oxaliplatin](https://www.frontiersin.org/files/Articles/1658001/xml-images/fmed-12-1658001-g0001.webp)
Not Applicable
![glutathione pulmonary fibrosis Idiopathic Fibrosis: Regulation, Cytokine Signaling, and Gaps in Our Knowledge[v1] Pulmonary Fibrosis Secondary to Oxaliplatin](https://www.nejm.org/cms/asset/99e482b2-5676-482c-aac2-ceb40e92c87e/nejme058210_f1.jpg)
